By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today announced the approval of almost MYR1.9 million ($608,000) in a seed capital grant from the Malaysian Biotechnology Corporation to support the commercial launch of the ColonSentry colorectal cancer diagnostic test in Malaysia.

The test will be made available in Malaysia through GeneNews Diagnostics, a privately held Malaysian firm that will also work with GeneNews to introduce ColonSentry in the rest of Southeast Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.